Results 31 to 40 of about 110,913 (253)

Screening for cervical cancer

Indian Journal of Medical Research, 2021
Cervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and ...
Rajaram, Shalini, Gupta, Bindiya
openaire   +2 more sources

Lack of consensus in calculation of interval cancer rates for cervical cancer screening

Acta Obstetricia et Gynecologica Scandinavica
Introduction In 2018, nondisclosure of results of retrospective audits of cytology in interval cancers precipitated a crisis in the Irish national cervical screening programme.
Patricia Fitzpatrick, Therese Mooney, Yvonne Williams, Caroline Mason Mohan, Jesper Bonde, Julia Gao, Andrzej Nowakowski, Annemie Haelens, Urska Ivanus, Maiju Pankakoski, Tina Karapetyan, Noirin E. Russell   +11 more
doaj   +1 more source

Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches

Radiology and Oncology, 2018
To overcome obstacles within the Slovenian organised cervical cancer screening programme, a randomised pilot study of human papillomavirus (HPV) self-sampling among non-attenders was performed, aiming to assess three different screening approaches.
Ivanus Urska, Jerman Tine, Fokter Alenka Repse, Takac Iztok, Prevodnik Veronika Kloboves, Marcec Mateja, Gajsek Ursula Salobir, Pakiz Maja, Koren Jakob, Celik Simona Hutter, Kramberger Kristina Gornik, Klopcic Ulrika, Kavalar Rajko, Zatler Simona Sramek, Kuzmanov Biljana Grcar, Florjancic Mojca, Nolde Natasa, Novakovic Srdjan, Poljak Mario, Zakelj Maja Primic   +19 more
doaj   +1 more source

Knowledge, willingness, uptake and barriers of cervical cancer screening services among Chinese adult females: a national cross-sectional survey based on a large e-commerce platform

BMC Women's Health, 2023
Background Improving the coverage rate of cervical cancer screening is a challenge mission for cervical cancer elimination. This study attempted to assess the knowledge, willingness, and uptake of cervical cancer screening services among Chinese females ...
Bo Zhang, Sumeng Wang, Xiyu Yang, Mingyang Chen, Wenhui Ren, Yanping Bao, Youlin Qiao   +6 more
doaj   +1 more source

Primary cervical cancer screening

Cirugía y Cirujanos (English Edition), 2015
Cervico-uterine cancer screening with cytology decrease incidence by more than 50%. The cause of this cancer is the human papilloma virus high risk, and requires a sensitive test to provide sufficient sensitivity and specificity for early detection and greater interval period when the results are negative.
Vargas-Hernández, Víctor Manuel, Vargas-Aguilar, Víctor Manuel, Tovar-Rodríguez, José María   +2 more
openaire   +2 more sources

Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid‐derived monolayers compared to HeLa cells

FEBS Letters, EarlyView.
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi, Pilar Samperio Ventayol, Natalie Burkard, Nicolas Schlegel, Carmen Aguilar, Sina Bartfeld   +5 more
wiley   +1 more source

The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons

BMC Women's Health
Background Incarcerated women face significantly elevated cervical cancer risks compared to the general population due to higher human papillomavirus (HPV) prevalence, limited healthcare access, and socio-demographic vulnerabilities.
Ann-Chatrin Linqvist Leonardsen, Elin Englund, Ameli Trope, Mona Stensrud, Kristine Breivik, Ragnhild Marie Nødtveidt   +5 more
doaj   +1 more source

The newfound relationship between extrachromosomal DNAs and excised signal circles

FEBS Letters, EarlyView.
Extrachromosomal DNAs (ecDNAs) contribute to the progression of many human cancers. In addition, circular DNA by‐products of V(D)J recombination, excised signal circles (ESCs), have roles in cancer progression but have largely been overlooked. In this Review, we explore the roles of ecDNAs and ESCs in cancer development, and highlight why these ...
Dylan Casey, Zeqian Gao, Joan Boyes
wiley   +1 more source

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

The Lancet Public Health
Summary: Background: Human papillomavirus (HPV)-based cervical screening is a globally recommended public health policy. Randomised clinical trials find superior performance of primary HPV-based screening compared with cytology for preventing cervical ...
Jiangrong Wang, PhD, K Miriam Elfström, PhD, Joakim Dillner, ProfMD   +2 more
doaj   +1 more source

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

Papillomavirus Research, 2019
Aim: Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial data suggest that one dose prevents HPV infection.
Julia ML. Brotherton, Alison Budd, Christopher Rompotis, Natasha Bartlett, Michael J. Malloy, Rachael L. Andersen, Kim AR. Coulter, Peter W. Couvee, Nerida Steel, Gail H. Ward, Marion Saville   +10 more
doaj   +1 more source